Going BIG: Daphne Zohar on “Close to the Edge”

The PureTech Health CEO in an exclusive interview for the new GEN Edge show

PureTech Health has about two dozen products in the pipeline, many of which revolve around the company’s main focus—the BIG (Brain-Immune-Gut) axis. Other areas of interest include cancer, neuroscience and long COVID . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

Previous articleHeart of the Deal: Prothena Executives on the $1.2B Sale of ATTR Amyloidosis Candidate to Novo Nordisk
Next articleFor Cell and Gene Therapy Products, Early Characterization is Critical